Global life reinsurance provider Reinsurance Group of America (NYSE: RGA) reported Q3 2026 results exceeding the market’s revenue expectations, with sales up 22.7% year on year to $7.67 billion. Its non-GAAP profit of $8.49 per share was 22.2% above analysts’ consensus estimates.

Is now the time to buy RGA? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

Reinsurance Group of America delivered a quarter that surpassed Wall Street’s expectations, with management attributing results to both strong global underwriting and robust investment income across all regions. CEO Tony Cheng highlighted "favorable economic claims experience and successful in-force management actions," pointing to effective risk selection and disciplined capital deployment. The Americas benefited from pension risk transfer deals and sound underwriting, while Asia Pacific and EMEA saw momentum from recent product launches and client partnerships. Management credited the company’s biometric expertise and diversified investment platform as central to its performance this quarter.

Looking forward, Reinsurance Group of America’s outlook is anchored in its ability to maintain disciplined growth in core markets and expand its capital management strategies. Management emphasized ongoing investment in risk analytics and the integration of third-party capital, with Cheng stating, "Our pipeline for both in-force and flow business remains attractive, and our confidence in 2026 and beyond remains high." The company plans to further leverage its global platform to pursue high-quality transactions, while adjusting to evolving regulatory requirements and refining reporting structures to improve transparency for stakeholders.

Key insights from management’s remarks

Management attributed the quarter’s outperformance to resilient underwriting results, strategic capital deployment, and favorable investment gains, while ongoing product and platform investments set the stage for future growth.

• Underwriting momentum in the Americas: Management cited strong underwriting outcomes and completion of four pension risk transfer transactions, signaling healthy client demand and continued market opportunity in both the U.S. and U.K. longevity segments.
• Favorable investment returns: The company’s variable investment income benefited from higher market yields and well-timed asset allocation, with new money rates exceeding portfolio averages. This investment performance provided a meaningful tailwind for both current earnings and future reinvestment.
• In-force management actions: Ongoing optimization of the existing business mix delivered incremental value, with actions in uncapped cohorts increasing the earnings run rate. Management reiterated that such initiatives remain a core lever for profitability, though timing and scale may fluctuate.
• Biometric and digital expertise: RGA’s ability to blend biometric risk assessment with digital underwriting solutions drove new business wins in Asia, particularly in Hong Kong and Japan. Management highlighted the launch of a simplified underwriting product in Japan and digital underwriting advances in Hong Kong as competitive differentiators.
• Third-party capital strategy: The full deployment of Ruby Re capital illustrates RGA’s strategy of co-investing alongside external capital sources, generating incremental fee income while supporting growth and maintaining balance sheet flexibility.

Drivers of future performance

Management expects future growth to be guided by disciplined underwriting, capital deployment, and enhancements to investment and digital capabilities, with ongoing regulatory shifts and capital management shaping the outlook.

• Pipeline of high-quality deals: RGA’s pipeline includes both in-force and flow business opportunities across core regions, with management forecasting attractive risk-adjusted returns from ongoing pension risk and biometric transactions. The company’s local expertise and selective approach are expected to sustain new business momentum despite market competition.
• Capital and investment strategy evolution: The integration of third-party capital, such as Ruby Re, will remain a priority, providing the ability to scale growth without disproportionate balance sheet risk. Management also pointed to ongoing asset allocation adjustments to benefit from high reinvestment rates, supporting long-term earnings.
• Regulatory and reporting changes: Management acknowledged that changes in reporting structure and evolving regulatory frameworks, including those from the NAIC (National Association of Insurance Commissioners), could impact business mix and capital requirements. The company is preparing to simplify segment reporting and enhance transparency to better align with internal management and stakeholder needs.

Catalysts in upcoming quarters

In upcoming quarters, our analysts will watch (1) the pace and quality of new deal flow, especially in pension risk transfer and biometric risk segments; (2) the impact of third-party capital deployment, such as future sidecar launches and Ruby Re’s ongoing contributions; and (3) the effectiveness of reporting simplification and transparency initiatives. Evolving global regulation and capital management strategies will also be important for tracking RGA’s ability to sustain outperformance.

Reinsurance Group of America currently trades at $267.22, up from $261.96 just before the earnings. Is there an opportunity in the stock? The answer lies in our full research report (it’s free).

High quality stocks for all market conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.